Fungal cell envelope

The fungal cell envelope is a complex, multi-layered structure essential for the survival, growth, and virulence of fungal pathogens (Source: NIH, PMC7149631). It primarily consists of an inner plasma membrane rich in ergosterol and an outer cell wall composed of a cross-linked network of chitin, beta-glucans, and mannoproteins (Source: StatPearls, NBK470441). This structure provides mechanical strength to withstand high internal osmotic pressure and serves as a primary interface for host-pathogen interactions (Source: Wikipedia, Fungal cell wall). Because many components of the fungal cell envelope, such as ergosterol and beta-glucans, are absent in mammalian cells, they represent ideal targets for selective antifungal therapy (Source: PubMed, 28214511). Major classes of drugs like polyenes, azoles, and echinocandins exert their effects by disrupting membrane integrity or inhibiting the synthesis of these vital structural components (Source: PubChem). Consequently, the fungal cell envelope is the focal point for treating a wide range of infections, from superficial mycoses to life-threatening systemic candidiasis and aspergillosis (Source: Merck Manual). Therapeutic challenges include the emergence of resistance and the potential for toxicity due to similarities between certain fungal and human metabolic pathways (Source: NIH, LiverTox).

Other names

Fungal cell wallFungal plasma membraneFungal cell surfaceFungal integument

Drugs targeting the fungal cell envelope operate through three primary mechanisms: inhibition of (1,3)-beta-D-glucan synthesis in the cell wall (echinocandins), inhibition of ergosterol biosynthesis in the plasma membrane (azoles and allylamines), and direct disruption of membrane integrity via ergosterol binding and pore formation (polyenes) (Source: StatPearls, NBK470441; PubMed, 28214511).